{
  "kind": "treatment",
  "slug": "cyproheptadine-periactin",
  "type": "antihistamine",
  "name": "Cyproheptadine (Periactin)",
  "summary": "A first-generation antihistamine with antiserotonergic properties, used for allergies, appetite stimulation, and serotonin syndrome management.",
  "description": "Cyproheptadine is a first-generation antihistamine that also antagonizes serotonin receptors (5-HT2) and muscarinic acetylcholine receptors. It is used for allergic conditions, as an appetite stimulant, and in the treatment of serotonin syndrome. Its sedative properties are significant due to central H1 receptor blockade.",
  "category": "medications/antihistamines",
  "tags": [
    "antihistamine",
    "antiserotonergic",
    "appetite-stimulant",
    "serotonin-syndrome"
  ],
  "metadata": {
    "drug_classes": [
      "First-Generation Antihistamine",
      "Antiserotonergic Agent"
    ],
    "therapeutic_categories": [
      "Allergies",
      "Appetite Stimulation",
      "Serotonin Syndrome"
    ],
    "mechanism_categories": [
      "Other"
    ],
    "administration_routes": [
      "Oral"
    ],
    "prescription_status": "Prescription Required",
    "controlled_substance": false,
    "generic_available": true,
    "brand_names": [
      "Periactin"
    ],
    "dea_schedule": null,
    "fda_pregnancy_category": "B",
    "age_groups": [
      "Adult",
      "Pediatric"
    ],
    "treatment_duration": [
      "Short-term",
      "Long-term"
    ],
    "specialty_areas": [
      "Allergy & Immunology",
      "Psychiatry",
      "Internal Medicine",
      "Pediatrics"
    ],
    "fda_approval_year": 1961
  },
  "clinical_metadata": {
    "primary_indications": [
      "Other"
    ],
    "off_label_uses": [
      "Migraine prophylaxis",
      "Cushing’s disease symptoms"
    ],
    "contraindications": [
      "Newborns",
      "Breastfeeding mothers",
      "Angle-closure glaucoma",
      "Stenosing peptic ulcer",
      "Bladder neck obstruction"
    ],
    "monitoring_required": [
      "Weight and appetite changes",
      "Sedation level",
      "Signs of anticholinergic burden"
    ],
    "efficacy_rating": {
      "allergies": 4,
      "appetite-stimulation": 4,
      "serotonin-syndrome": 3
    }
  },
  "search_metadata": {
    "searchable_terms": [
      "cyproheptadine",
      "periactin",
      "antihistamine",
      "appetite stimulant",
      "serotonin antagonist"
    ],
    "synonyms": [
      "cyproheptadine hydrochloride"
    ],
    "common_misspellings": [
      "cyproheptadin",
      "cyprhoheptadine"
    ]
  },
  "sections": [
    {
      "type": "indications",
      "items": [
        "Allergic rhinitis",
        "Urticaria",
        "Appetite stimulation (e.g., cancer-related cachexia, pediatric underweight)",
        "Serotonin syndrome"
      ]
    },
    {
      "type": "mechanism",
      "text": "Cyproheptadine blocks histamine H1 receptors, serotonin 5-HT2 receptors, and muscarinic receptors. The antiserotonergic effect makes it useful in serotonin syndrome and appetite stimulation."
    },
    {
      "type": "dosing",
      "adult": {
        "allergic-disorders": "4 mg every 8 hours; may increase to 20–32 mg/day in divided doses",
        "appetite-stimulation": "2 mg two to three times daily; may titrate",
        "serotonin-syndrome": "4–8 mg every 1–4 hours until symptoms resolve (acute use)"
      },
      "pediatric": "Varies by age; typically 0.25 mg/kg/day in divided doses for allergy indications",
      "geriatric": "Use with caution; increased anticholinergic sensitivity"
    },
    {
      "type": "dosage_forms",
      "items": [
        "Tablets: 4 mg",
        "Syrup: 2 mg/5 mL"
      ]
    },
    {
      "type": "onset_duration",
      "text": "Onset within 1–3 hours; duration of action approximately 4–6 hours."
    },
    {
      "type": "adverse_effects",
      "common": [
        "sedation",
        "dry mouth",
        "dizziness",
        "increased appetite",
        "weight gain"
      ],
      "less_common": [
        "confusion",
        "constipation",
        "blurred vision"
      ],
      "serious": [
        "urinary retention",
        "angle-closure glaucoma",
        "severe anticholinergic toxicity in overdose"
      ]
    },
    {
      "type": "warnings",
      "black_box": null,
      "other": [
        "Significant sedation may impair performance of hazardous activities",
        "Caution in elderly due to anticholinergic load",
        "Avoid in infants due to paradoxical CNS excitation"
      ]
    },
    {
      "type": "interactions",
      "items": [
        {
          "with": "CNS depressants",
          "risk": "Additive sedation",
          "action": "Monitor and use caution"
        },
        {
          "with": "MAOIs",
          "risk": "Prolonged and intensified anticholinergic effects",
          "action": "Avoid"
        },
        {
          "with": "Other anticholinergics",
          "risk": "Additive anticholinergic burden",
          "action": "Use caution"
        }
      ]
    },
    {
      "type": "monitoring",
      "items": [
        "Weight and BMI during chronic use",
        "Sedation level",
        "Signs of urinary retention",
        "Bowel function"
      ]
    },
    {
      "type": "special_populations",
      "pregnancy": "Category B; use if benefits outweigh risks",
      "lactation": "Avoid; may cause sedation in infant",
      "pediatrics": "Avoid in newborns; safe in older children with dosing adjustment",
      "geriatrics": "Caution due to increased CNS and anticholinergic sensitivity"
    },
    {
      "type": "tapering",
      "text": "Generally not required for short-term use; taper may be considered after prolonged high-dose use to avoid rebound symptoms."
    },
    {
      "type": "clinical_notes",
      "items": [
        "One of the few serotonin antagonists available for serotonin syndrome treatment",
        "Often used off-label for appetite stimulation in chronic illness and pediatrics",
        "Less commonly used for allergies compared to newer non-sedating antihistamines"
      ]
    },
    {
      "type": "references",
      "items": [
        {
          "label": "Periactin Prescribing Information",
          "url": "https://www.accessdata.fda.gov/"
        },
        {
          "label": "Serotonin Syndrome Management Guidelines",
          "url": "https://pubmed.ncbi.nlm.nih.gov/"
        }
      ]
    }
  ],
  "seo": {
    "title": "Cyproheptadine (Periactin): Antihistamine and Serotonin Antagonist",
    "description": "Cyproheptadine (Periactin) is a first-generation antihistamine with serotonin antagonism, used for allergies, appetite stimulation, and serotonin syndrome."
  }
}
